CALIFORNIA SOCIETY OF HEALTH-SYSTEM PHARMACY 2015 REVIEW OF CSHP ADMINISTRATIVE POLICIES 5 YEARS AND OLDER
|
|
- Chad Copeland
- 5 years ago
- Views:
Transcription
1 2015 REVIEW OF CSHP ADMINISTRATIVE POLICIES 5 YEARS AND OLDER The following CSHP administrative policies are to be reaffirmed, deleted, or modified and reaffirmed as indicated. Policy #: Assigned to: Marty Torres, Claire Action: Delete Spahn, Gollapudi Shankar : Pharmacist Certification, Credentials, and the Credentialing Process Source: HOD 2000 (Note: This is former policy # approved by the HOD in 2000; reaffirmed by the HOD in 2005 as policy # ; reaffirmed by the HOD in 2010 as policy # ) CSHP supports: 1. The approach being proposed by the Council on Credentialing in Pharmacy (CCP), which includes: a. The systematic development and implementation of standards for certification, credentials, and credentialing processes in the pharmacy profession. b. The systematic development and implementation of nationwide, profession-wide systems for certification and credentials. c. The development of a systematic approach to determining the need for current and future certifications and credentials for pharmacy practice based on the needs of the public, health care system and pharmacy profession. d. The development and implementation or adoption of a nationwide, profession-wide credentialing system for pharmacy practice. e. To work in collaboration with other members of the health care system in the achievement of a-d. 2. The concept of requiring periodic re-certification for advanced practice roles. 3. The treatment of certification, credentials, credentialing, and payment for pharmacists services as separate issues. 4. The concept of requiring accreditation of pharmacy certifying and credentialing organization(s). 5. The development of a time-limited mechanism to recognize practitioners certified under the current BPS, CCG and DSM systems, if they are actively practicing in their area(s) of certification during the development of a nationwide, profession-wide certification program. 1. Council on Credentialing in Pharmacy. Guiding principles for post-licensure credentialing of pharmacists [2011]. Files/GuidingPrinciplesPharmacistCredentialing.pdf 2. Credentialing and privileging of pharmacists: A resource paper from the Council on Credentialing in Pharmacy Council on Credentialing in Pharmacy Am J Health-Syst Pharm. 2014; 71: ,
2 Page 2 of 24
3 Page 3 of 24 Policy #: Assigned to: Marty Torres, Donna Action: Reaffirm Luong : Collective Bargaining Source: HOD 1989 (Note: This is former policy #8906 approved by the HOD in 1989; reaffirmed by the HOD in 1995 as policy #9502; reaffirmed by the HOD in 2000 as policy # ; modified and reaffirmed by the HOD in 2005 as policy # ; reaffirmed by the HOD in 2010 as policy # ) CSHP is a professional organization committed to upholding the standards of practice in the profession of pharmacy. CSHP remains separate and apart from any collective bargaining entity. It appears the intent of this policy is to state that CSHP is neutral regarding collective bargaining in general, as such, this policy is current and no change is needed.
4 Page 4 of 24 Policy #: Assigned to: Betty Jue, Fred Action: Reaffirm Shackelford : ASHP Policies Source: HOD 1987 (Note: This is former policy #8711 approved by the HOD in 1987; reaffirmed by the HOD in 1993 as policy #9324; reaffirmed by the HOD in 1998 as policy #9807; modified and reaffirmed by the HOD in 2000 as policy # ; modified and reaffirmed by the HOD in 2005 as policy # ; modified and reaffirmed by the HOD in 2010 as policy # ) To adopt as CSHP policy all ASHP Policy Positions, Guidelines, Bulletins and all official Statements in the current edition of the Best Practices for Health-System Pharmacy of the ASHP, except when such policies differ substantially from CSHP policy. To endorse the use of ASHP Position Statements, Guidelines and Technical Assistance Bulletins by its members in their practice settings. This policy is still current and reflects the CSHP strategic plan.
5 Page 5 of 24 Policy #: Assigned to: William Alger, Donna Action: Reaffirm Luong : Pharmacist License Renewal Source: BOD 1993 (Note: This is former policy #9302 approved by the HOD in 1993; modified and reaffirmed by the HOD in 1998 as policy #9810; modified and reaffirmed by the HOD in 2000 as policy # ; modified and reaffirmed by the HOD in 2005 as policy # ; modified and reaffirmed by the HOD in 2010 as policy # ) CSHP opposes the use of examinations for the purpose of pharmacist license renewal, notwithstanding Board of Pharmacy Disciplinary Action. No similar policy from ASHP or CPHA could be found. ASHP policies (1111 & 1014) provide general recommendations regarding CE and Training but this CSHP policy is more specific to its intent regarding opposition to the use of examinations.
6 Page 6 of 24 Policy #: Assigned to: Marty Torres, Action: Reaffirm Suzanne Shea, Douglas Barcon : Pharmacists Scope of Practice: Efforts to Restrict Source: HOD 2000 (Note: This is former policy # approved by the HOD in 2000; modified and reaffirmed by the HOD in 2005 as policy # ; modified and reaffirmed by the HOD in 2010 as policy # ) CSHP opposes efforts that restrict pharmacists scope of practice or limit the pharmacists role in the medication use process. Examples of such efforts include, but are not limited to, legislation or regulations and/or policies and procedures that: 1. In the area of prescribing: a. Rescind or limit pharmacists scope of practice in any patient care setting. 2. In the area of dispensing, preparation and distribution: a. Restrict pharmacists ability to provide specialty medications to patients by implementing limited distribution systems for selected products. b. Restrict pharmacists ability to substitute generic medications. c. Restrict pharmacists ability to use formularies or physician-approved therapeutic substitutions. d. Restrict pharmacists use of professional judgment. 3. In the area of medication administration: a. Eliminate the requirement for pharmacist verification of the medication orders prior to administration to patients. b. Restrict the pharmacists ability to administer immunizations. 4. In the area of patient monitoring of medication effects: a. Restrict the pharmacists ability to provide patient education on the safe use of medications. b. Restrict the pharmacists ability to properly monitor medications to assure safe use and minimize adverse effects. c. Restrict pharmacists ability to provide therapeutic drug monitoring or other monitoring services. 5. In the area of medication process oversight and responsibility a. Restrict the pharmacists responsibility for the medication use process. This policy is still current in today s pharmacy practice environment regarding efforts to restrict pharmacist scope of practice. However, SB-493 does incorporate a restrictive element by not grandfathering pharmacists who have more than five-years of clinical pharmacy experience in collaborative practice, such as in a hospital or ambulatory care clinic and do not have a residency or a
7 Page 7 of 24 certification. SB-493 favors new pharmacy school graduates who have minimal experience but have a residency and a certification over those pharmacists who have hands-on experience.
8 Page 8 of 24 Policy #: Assigned to: Claire Spahn, William Action: Reaffirm Alger : Funding, Expertise and Oversight of Pharmacy Practice Source: HOD 2005 (Note: This is former policy # approved by the HOD in 2005; reaffirmed by the HOD in 2010 as policy # ) 1. CSHP advocates appropriate oversight of pharmacy practice (including nontraditional practice) and the pharmaceutical supply chain by the state board of pharmacy and other state and federal agencies whose mission it is to protect the public health; further 2. CSHP advocates adequate representation on the state board of pharmacy and related state and federal agencies by pharmacists who are knowledgeable about hospitals and health systems to ensure appropriate oversight of hospitals and health-system pharmacy practice; further 3. CSHP advocates adequate funding for the state board of pharmacy and related state and federal agencies to ensure the effective oversight and regulation of pharmacy practice and the pharmaceutical supply chain. Recommend no change as it is already essentially the same as ASHP policy (0518)
9 Page 9 of 24 Policy #: Assigned to: Suzanne Shea, Action: Reaffirm Gollapudi Shankar : Conscientious Objection by Pharmacists to Morally, Religiously, or Ethically Troubling Therapies Source: HOD 1993 (Note: This is former policy #9316 approved by the HOD in 1993; reaffirmed by the HOD in 1998 as policy #9802; modified and reaffirmed by the HOD in 2003 as policy # ; modified and reaffirmed by the HOD in 2005 as policy # ; reaffirmed by the HOD in 2010 as policy # ) 1. CSHP recognizes a pharmacist s right to conscientious objection to morally, religiously or ethically troubling therapies; and 2. CSHP supports the development of systems to allow pharmacists to invoke the right to conscientiously object to morally, religiously or ethically troubling therapies, while ensuring the patient s right to obtain, in a timely manner, legally prescribed and/or medically indicated therapies. Policy is current. No changes recommended.
10 Page 10 of 24 Policy #: Assigned to: Betty Jue, Gollapudi Action: Delete Shankar : Diversity in Health Care and Pharmacy Source: HOD 2005 (Note: This is former policy # approved by the HOD in 2005; reaffirmed by the HOD in 2010 as policy # ) CSHP endorses programs, systems, and communications that: 1. Improve health-care outcomes through diversity initiatives; 2. Foster awareness of the impact of diversity in all its forms among health care providers by providing educational programs on evidence-based cultural issues and disparities; 3. Recognize the impact of health care provider diversity on the medication-use process; and 4. Develop and promote the weaving/embedding of diversity issues into many of CSHP s educational programs and articles. CSHP Professional Policy # directs CSHP to adopt ASHP policies and other guidance documents as CSHP Professional Policy: To adopt as CSHP policy all ASHP Policy Positions, Guidelines, Bulletins, and all official Statements in the current edition of the Best Practices for Health-System Pharmacy of the ASHP, except when such policies differ substantially from CSHP policy. In 2014, ASHP combined its cultural competence (ASHP #0314) and cultural diversity (#0409) policies into one which closely resembled CSHP s With these changes, COPA felt that the ASHP policy position do not differ substantially from CSHP s, hence the recommendation to delete CSHP policy and adoption of ASHP s policy.
11 Page 11 of 24 Policy #: Assigned to: Douglas Barcon, Action: Reaffirm Marty Torres : Importation of Pharmaceuticals Source: HOD 2005 (Note: This is former policy # approved by the HOD in 2005; reaffirmed by the HOD in 2010 as policy # ) To advocate for the continuation and application of laws and regulations enforced by the Food and Drug Administration and state boards of pharmacy with respect to the importation of pharmaceuticals in order to 1. maintain the integrity of the pharmaceutical supply chain and avoid the introduction of counterfeit products into the United States; 2. provide for continued patient access to pharmacist review of all medications and preserve the patient-pharmacist-prescriber relationship; and 3. provide adequate patient counseling and education, particularly to patients taking multiple highrisk medications; further, To urge the FDA and state boards of pharmacy to vigorously enforce federal and state laws in relation to importation of pharmaceuticals by individuals, distributors (including wholesalers), and pharmacies that bypass a safe and secure regulatory framework. CSHP supports greater affordability and access to needed medications in the United States. It is our opinion that any program that seriously attempts to reign in rising drug costs MUST involve pharmacists. CSHP encourages exploration and research into mechanisms that can be implemented to assure that all of the safeguards needed are feasible to assist our nation in continuing the drug importation debate. Until such research is performed, and safeguards are assured and in place, CSHP advocates for the continuation and application of laws and regulations enforced by the Food and Drug Administration and state boards of pharmacy with respect to the importation of pharmaceuticals in the United States and urges the FDA and state boards of pharmacy to vigorously enforce federal and state laws in relation to importation of pharmaceuticals by individuals, distributors (including wholesalers), and pharmacies that bypass a safe and secure regulatory framework.
12 Page 12 of 24 This policy is still current in today s regulatory and pharmacy practice environments.
13 Page 13 of 24 Policy #: Assigned to: William Alger, Betty Action: Modify & Reaffirm Jue : Redistribution of Unused Medications Source: HOD 2005 (Note: This is former policy # approved by the HOD in 2005; reaffirmed by the HOD in 2010 as policy # ) CSHP supports the concept of redistribution of previously dispensed, unused medications provided that adequate safeguards are in place. CSHP supports the concept of redistribution of previously dispensed, unused medications provided that adequate safeguards are in place and it is in compliance with Federal and State regulations. The State has regulation in place on this subject. CA Pharmacy Law Book -- Division 116 Surplus medication Collection and Distribution, Chapter 2 Health Facilities Regs , , , , , , , , and
14 Page 14 of 24 Policy #: Assigned to: Gollapudi Shankar, Action: Modify & Reaffirm Jasmine Reber : Use of Patient Identifiers at Time of Outpatient Prescription Dispensing Source: HOD 2010 CSHP supports accurate dispensing procedures to reduce medication errors for patients in the outpatient setting that include the use of at least two-identifiers ensuring patient identification at the time of prescription dispensing. CSHP supports accurate dispensing procedures to reduce medication errors for patients in the outpatient setting that include the use of at least two-identifiers ensuring patient identification at the time of prescription dispensing to the patient or the patient s agent within the current scope of state and federal regulations. Many patients are chronically ill and prescription dispensing often involve family members, long-term facility personnel, etc.
15 Page 15 of 24 Policy #: Assigned to: Fred Shackelford, Action: Modify & Reaffirm Jasmine Reber : Gifts to Pharmacists and Pharmacy Personnel from Industry Source: HOD 1991 (Note: This is former policy #9108 approved by the HOD in 1991; reaffirmed by the HOD in 1996 as policy #9601; reaffirmed by the HOD in 2001 as policy # ; reaffirmed by the HOD in 2006 as policy # ; modified and reaffirmed by the HOD in 2010 as policy # ) Pharmacists and pharmacy personnel should not solicit or accept gifts from industry that might influence or appear to influence objectivity, independence, or fairness in clinical and professional judgment. Pharmacists and pharmacy personnel may accept educational items only that do not have value outside of her or his professional responsibilities. Providing items for health care professionals use that do not advance disease or treatment education even if they are practice-related items of minimal value (such as pens, note pads, mugs and similar reminder items with company or product logos) may foster misperceptions that company interactions with health care professionals are not based on informing them about medical and scientific issues. Such non-educational items should not be offered to health care professionals or members of their staff, even if they are accompanied by patient or physician educational materials. Pharmacists and pharmacy personnel should not solicit or accept gifts from industry that might influence or appear to influence objectivity, independence, or fairness in clinical and professional judgment. Pharmacists and pharmacy personnel should not benefit personally from transactions outside from educational purposes from industries or suppliers even on the behalf of a business. These include, but are not limited to gifts, meals, entertainment, and grants. Pharmacists and pharmacy personnel may accept educational items only that do not have value outside of her or his professional responsibilities. Providing items for health care professionals use that do not advance disease or treatment education even if they are practice-related items of minimal value (such as pens, note pads, mugs and similar reminder items with company or product logos) may foster misperceptions that company interactions with health care professionals are not based on informing them about medical and scientific issues. Such non-educational items should not be offered to health care professionals or members of their staff, even if they are accompanied by patient or physician educational materials. Gifts include non-tangible items such as special events, items of value, etc., and are not appropriate for personal benefit.
16 Page 16 of 24 Policy #: Assigned to: Donna Luong, Action: Modify & Reaffirm Douglas Barcon : Assisting California Schools of Pharmacy Assess Healthcare and Manpower Demands Source: HOD 2010 The California Society of Health-System Pharmacists shall seek an active role in assisting California schools of pharmacy and proposed schools of pharmacy to assess current and future healthcare demands, and manpower needs. The California Society of Health-System Pharmacists shall seek an active role in assisting California schools of pharmacy and proposed schools of pharmacy to assess current and future healthcare demands, and manpower needs. CSHP: 1. Advocates for high quality pharmacist education by new and proposed accredited schools of pharmacy. 2. Supports that new and current schools of pharmacy must provide and maintain sufficient highquality IPPE and APPE experiential sites for their students enrolled in their doctor of pharmacy programs. 3. Supports that proposed schools of pharmacy must secure sufficient high-quality IPPE and APPE experiential sites for their potential doctor of pharmacy candidates prior to admission of the inaugural class and grant of accreditation. 4. Supports the expansion of pharmacy schools and enrollment in existing or new colleges of pharmacy only when well-designed projections demonstrate that such expansion is necessary to maintain a sufficient and balanced pharmacist workforce in California. 5. Supports the expansion of post-graduate pharmacy training programs such as PGY1 residency programs in California. The Sherman Antitrust Act prohibits interference with free trade, such as the opening of new schools of pharmacy regardless of need. Only the market can determine the number of pharmacists needed in California regardless of tuition costs and the ability of pharmacy students to secure financing for their education and ability for future repayment of student loans. Overall quality of pharmacy education is related to the quality of the education provided in IPPE and APPE experiential programs. Without sufficient high-quality experiential sites, the quality of education provided to pharmacy school students suffers, and this in turn impacts the student upon graduation and their ability practice pharmacy at a doctor of pharmacy level. ASHP has policy 1108 Quality of Pharmacy Education and Expansion of Colleges of Pharmacy and policy 1201 Preceptor Skills and Abilities. This policy differs substantially from these ASHP policies.
17 Page 17 of 24 Policy #: Assigned to: Claire Spahn, Action: Reaffirm Jasmine Reber : Uniformity of Controlled Medications for Federal and State Classifications Source: HOD 2010 The California Society of Health-System Pharmacists supports uniformity for controlled medications between federal and state classifications. We agree with retaining the above wording but wonder whether we should also address classifications that may conflict and whether to defer to federal law or to the more stringent of the 2 (state vs. federal) classifications in such a case? For example, Paregoric (tincture of opium is a CII in California, but a CIII federally) Also, our committee s STP on medical marijuana supports changing its classification to schedule II, although it is schedule I federally
18 Page 18 of 24 Policy #: Assigned to: Suzanne Shea, Fred Action: Reaffirm Shackelford : Sales Tax Exemption on Prescribed Medications and Medical Equipment Source: HOD 2010 The California Society of Health-Systems Pharmacists supports the exemption of sales tax on prescribed purchases of medications, medical supplies, equipment, and devices. This policy is still current. No changes needed.
19 Page 19 of 24 Policy #: Assigned to: Jasmine Reber, Action: Reaffirm Claire Spahn : Requiring the Purpose of a Prescribed Medication on the Label Source: HOD 2010 The California Society of Health-System Pharmacists supports requiring that the purpose of a prescribed medication be included on all prescriptions, and that the purpose of the medication be included on the medication label. In recognition of a patient s right to privacy, CSHP supports allowing patients to opt out of having the purpose printed on the label upon request. We agree with keeping the current wording; our rationale: the Board of Pharmacy surveyed consumers/patients regarding this issue please see results in the linked report below
20 Page 20 of 24 Policy #: Assigned to: Suzanne Shea, Fred Action: Delete Shackelford : Third Party Insurance Cards Source: HOD 2010 The California Society of Health-System Pharmacists supports: 1. The uniformity of content for all third party insurance cards; 2. Third party payers to provide information on patient identification cards to facilitate efficient claims processing, including adoption of a standardized system of identifying numbers for members and their dependents. Policy is still current. Policy deleted by HOD in November 2014.
21 Page 21 of 24 Policy #: Assigned to: William Alger, Donna Action: Modify & Reaffirm Luong : Pharmacy Staff Training to Identify Victims of Abuse, Neglect, or Domestic Violence Source: HOD 2010 The California Society of Health-System Pharmacists supports the education and training of pharmacy staff to recognize patients who may be victims of child and elder abuse or neglect, or domestic violence and refer them to appropriate local programs. The California Society of Health-System Pharmacists supports the education and training of pharmacy staff to recognize patients who may be victims of child and elder abuse or neglect, or domestic violence/abuse and refer them to appropriate local programs. No similar ASHP policies and it would appear that CSHP is taking the lead in this area. Recommend no change as this CSHP policy is clear and succinct while not being too prescriptive.
22 Page 22 of 24 Policy #: Assigned to: Douglas Barcon, Action: Modify & Reaffirm Betty Jue : Emergency Preparedness and Response Source: HOD 2006 (Note: This is former policy # approved by the HOD in 2006; modified and reaffirmed by the HOD in 2010 as policy # ) CSHP supports the participation of pharmacists in the development and execution of federal, state and local emergency preparedness and response guidelines by: 1. Involving pharmacists and pharmacy staff in the planning and execution of pharmaceutical distribution and medication management of patients during disasters. 2. Classifying pharmacists as First Responder Health Workers if they choose to seek this designation. 3. Assisting public health officers in relaying health information to the community. 4. Encouraging all pharmacists to obtain and maintain competency in basic cardiac life support; and 5. Encouraging all pharmacists and pharmacy staff to volunteer in advance of a disaster. 6. Encouraging pharmacists and pharmacy staff to register as a State of California Disaster Health Care Volunteer. 7. Recommending the California Office of Emergency Services to allow licensed pharmacists to cross emergency lines to render services. CSHP supports the participation of pharmacists in the development and execution of federal, state and local emergency preparedness and response guidelines to: A. Prevent or minimize repercussions and effects of a disaster upon an institution, community, and individuals. 1. CSHP strongly encourages pharmacists becoming well informed about the local history of and potential for natural disasters and industrial accidents, as well as the threat of terrorist attacks with WMD, including potential agents that could be used and the related diagnostic and treatment issues. 2. CSHP supports pharmacist assistance to public health officers in relaying health information to the community. 3. CSHP encourages pharmacists and pharmacy technicians to consider volunteering in advance of a disaster.
23 Page 23 of CSHP encourages pharmacist and pharmacy technician involvement in community based emergency response teams, i.e., Community Emergency Response Team (CERT) 5. CSHP adopt ASHP Statement on the Role of Health-System Pharmacists in Emergency Preparedness: B. Utilize their skills and training to provide safe medication usage, medication distribution, and victim safety from initial response through recovery stemming from a disaster or emergency situation 1. CSHP encourages pharmacists to consider volunteering to assist in (a) distributing emergency supplies of pharmaceuticals, (b) dispensing and administering medications and immunizations, and (c) managing the drug therapy of individual victims. 2. CSHP supports a recommendation to the California Office of Emergency Services to allow licensed pharmacists to cross emergency lines to render services. C. Train and prepare pharmacy staff to respond effectively to disasters and emergency crises from initial response through demobilization. 1. CSHP supports classifying pharmacists as First Responder Health Workers if they choose to seek this designation. 2. CSHP encourages pharmacists and pharmacy technicians to register as a State of California Disaster Health Care Volunteer. 3. CSHP encourages all pharmacists and pharmacy technicians to develop and maintain first-aid skills and complete and maintain basic cardiac life support (BCLS) certification. 4. CSHP encourages pharmacists to be trained and knowledgeable of the FEMA National Incident Management System, at least, through IS-200 level for healthcare professionals. 5. CSHP supports pharmacist involvement in the planning and execution of pharmaceutical distribution and medication management of patients during disasters. D. Identify essential resources needed for disaster relief and recovery and assist in facilitating appropriate conservation, distribution, and utilization. 1. CSHP strongly encourages pharmacists and pharmacy staff becoming well informed of local and institutional plans for emergency preparedness, especially those related to the distribution, control, and use of pharmaceuticals.
24 Page 24 of CSHP strongly discourages individuals from developing personal stockpiles of pharmaceuticals for use in the event of chemical, biological, or nuclear terrorism without regard to local emergency preparedness plans designed to meet the needs of the whole community. : In order for a pharmacist to function in an emergency or disaster incident, he or she must understand the standard terminology used by responders and incident command staff, how the incident management system works, and where they fit into the response team. Without such a statement in the policy, pharmacists may not be able to participate in emergency preparedness and disasters as described in this policy. ASHP Statement on the Role of Health-System Pharmacists in Emergency Preparedness
Policies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More information2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017
2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen
More information2018 House of Delegates Report of the Policy Review Committee
8 2018 House of Delegates Report of the Policy Review Committee Policies last reviewed in 2013 Policies Related to Newly Adopted Policies from 2017 HOD Statements Organized by Recommendation Committee
More informationASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics. March 2018
ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics March 2018 Introduction Improving patient access to affordable medicines is a core value of companies that develop and manufacture generic and
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More information2016 House of Delegates Report of the Policy Review Committee
2016 House of Delegates Report of the Policy Review Committee Part I Policies last reviewed in 2011 Statements Organized by Recommendation Statements to Accompany New Business Items Part II Policies related
More informationBe it enacted by the General Assembly of the Commonwealth of Kentucky: Section 1. KRS is amended to read as follows:
AN ACT relating to the prescriptive authority of advanced practice registered nurses. Be it enacted by the General Assembly of the Commonwealth of Kentucky: Section. KRS.0 is amended to read as follows:
More informationColorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
More informationCHAPTER 29 PHARMACY TECHNICIANS
CHAPTER 29 PHARMACY TECHNICIANS 29.1 HOSPITAL PHARMACY TECHNICIANS 1. Proper Identification as Pharmacy Technician 2. Policy and procedures regulating duties of technician and scope of responsibility 3.
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More information78th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill 2028 SUMMARY
Sponsored by COMMITTEE ON HEALTH CARE th OREGON LEGISLATIVE ASSEMBLY-- Regular Session House Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Patricia M. D Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control May 30, 2015 Organization Health
More informationOpp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL Phone Number: (334)
Opp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL 36467-1695 Phone Number: (334) 493-4558 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW
More informationAN ACT. Be it enacted by the General Assembly of the State of Ohio:
(131st General Assembly) (Substitute House Bill Number 124) AN ACT To amend section 4729.01 and to enact sections 4723.4810, 4729.282, 4730.432, and 4731.93 of the Revised Code regarding the authority
More informationPractice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey
Practice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey Jodie Elder, PharmD, BCPS September 14, 2017 Objectives List the key components of the Practice Advancement
More informationReport of the Task Force on Standardization of Technicians Role and Competencies
Report of the Task Force on Standardization of Technicians Role and Competencies Members Present: A. Jeffrey Newell (RI), chair; B. Belaire Bourg, Jr. (LA); Eugene P. Drake (AZ); Jeanne G. Furman (MD);
More informationHIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices Georgia Mountains Hospice understands that your health information is highly personal and we are committed to safeguarding your privacy. Please read this Notice of Privacy
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationProfessional Practices Policy (P3)
Novartis Global Policy Professional Practices Policy (P3) Novartis Global Policy March 1st, 2018 Version GIC 102.V1.EN NOVARTIS GLOBAL POLICY 2 Contents 1 Introduction... 3 2 Principles... 4 3 Policy...
More informationNOTICE OF PRIVACY PRACTICES MOUNT CARMEL HEALTH SYSTEM
NOTICE OF PRIVACY PRACTICES MOUNT CARMEL HEALTH SYSTEM Effective Date: 9/23/ 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
More informationExperiential Education
Experiential Education Experiential Education Page 1 Experiential Education Contents Introduction to Experiential Education... 3 Experiential Education Calendar... 4 Selected ACPE Standards 2007... 5 Standard
More informationBUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL INDUSTRY REPRESENTATIVES
Department of Veterans Affairs MEMORANDUM NO. 119-11 North Florida/South Georgia Veterans Health System Change 2 June 1, 2005 BUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL INDUSTRY REPRESENTATIVES
More informationCommonwealth Health Corporation Notice of Privacy Practices CHC COMMONWEALTH HEALTH CORPORATION
CHC COMMONWEALTH HEALTH CORPORATION NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 Revised: September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS
More informationCHI Mercy Health. Definitions
CHI Mercy Health Definitions If you have any questions about this notice, please contact the CHI Mercy Health s Privacy Office at (701) 845-6540 or 570 Chautauqua Blvd, Valley City ND 58072. Notice of
More informationStatement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association
Statement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association Food and Drug Administration [Docket Nos. FDA 2010 N 0284 and FDA 2009 D
More informationAshe Memorial Hospital, Inc. 200 Hospital Avenue, Jefferson, NC (336) JOINT NOTICE OF PRIVACY PRACTICES
Ashe Memorial Hospital, Inc. 200 Hospital Avenue, Jefferson, NC 28640 (336) 846-7101 JOINT NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More information5ESSB 5857 Regulation Pharmacy Benefit Managers Signed into law April 1, 2016
WSPA/LRAC Bill Tracking Update April 18, 2016 FINAL REPORT 5ESSB 5857 Regulation Pharmacy Benefit Managers Signed into law April 1, 2016 Transfers regulatory oversight of Pharmacy Benefit Manager (PBMs)
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES 1 Effective Date: April 14, 2003 Revision Date: September 23, 2013 Revision Date: January 17, 2018 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationADVOCATE HEALTH CARE GUIDELINES FOR VENDOR RELATIONS
ADVOCATE HEALTH CARE GUIDELINES FOR VENDOR RELATIONS PURPOSE: To provide guidelines for ethical conduct to all Advocate Health Care associates and physicians, as well as individuals and organizations who
More information> TITLE 13. LAW AND PUBLIC SAFETY
N.J.A.C. 13:45J-1.1 13:45J-1.1 Purpose The rules in this chapter regulate the receipt and acceptance by prescribers of anything of value from pharmaceutical manufacturers to ensure that such relationships
More informationStephen C. Joseph, M.D., M.P.H.
JUL 26 1995 MEMORANDUM FOR: ASSISTANT SECRETARY OF THE ARMY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE NAVY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE AIR FORCE (MANPOWER, RESERVE
More informationDaiichi Sankyo Group Global Marketing Code of Conduct
Daiichi Sankyo Group Global Marketing Code of Conduct TABLE OF CONTENTS 1. PURPOSE... 3 2. SCOPE... 3 3. TERMS... 3 4. COMPLIANCE WITH LOCAL LAWS, REGULATIONS AND INDUSTRY CODES... 4 5. BASIS OF INTERACTIONS...
More informationWAKE FOREST BAPTIST HEALTH NOTICE OF PRIVACY PRACTICES
WAKE FOREST BAPTIST HEALTH NOTICE OF PRIVACY PRACTICES Effective April 14, 2003 Revised February 17, 2010 Revised September 23, 2013 Revised July 1, 2016 This Notice of Privacy Practices applies to the
More informationELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES
ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES Introduction The competency areas, goals, and objectives are for use with the ASHP Accreditation Standard
More informationBUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL COMPANY REPRESENTATIVES
Department of Veterans Affairs MEMORANDUM NO. 119-11 North Florida/South Georgia Veterans Health System Change 5 March 15, 2013 BUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL COMPANY REPRESENTATIVES
More informationNotice of Privacy Practices
2269 CHERRY VALLEY ROAD, NEWARK, OH 43055 (740) 788-1400 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW
More informationHIPAA PRIVACY NOTICE
HIPAA PRIVACY NOTICE PLEASE REVIEW THIS NOTICE CAREFULLY. IT DESCRIBES HOW YOUR MEDICAL INFORMATION MAY BE USED AND DISCLOSED AND HOW YOU MAY GAIN ACCESS TO THAT INFORMATION. POLICY STATEMENT This Practice
More informationThe District of Columbia Death with Dignity Act (Patient Request for Medical Aid-in-Dying)
Office of Origin: I. PURPOSE II. A. authorizes medical aid in dying and allows an adult patient with capacity, who has been diagnosed with a terminal disease with a life expectancy of six months or less,
More informationSECTION HOSPITALS: OTHER HEALTH FACILITIES
SECTION.1400 - HOSPITALS: OTHER HEALTH FACILITIES 21 NCAC 46.1401 REGISTRATION AND PERMITS (a) Registration Required. All places providing services which embrace the practice of pharmacy shall register
More informationCreating the future. Celebrating the past. Learning Objectives. Disclosure. How Provider Status, PAI, and YOU Can Impact the Future of Pharmacy
Creating the Future How Provider Status, PAI, and YOU Can Impact the Future of Pharmacy Aretha Hankinson, J.D. Director, Advocacy Communications ASHP Learning Objectives Identify the steps that the profession
More informationMarketing. Pharmaceutical Industry: Marketing Positions 445
Marketing Pharmaceutical Industry: Marketing Positions 445 Restricted Drug Distribution (1714) To oppose restricted drug distribution systems that (1) limit patient access to medications; (2) undermine
More informationNOTICE OF PRIVACY PRACTICES UNIVERSITY OF CALIFORNIA RIVERSIDE CAMPUS HEALTH CENTER
NOTICE OF PRIVACY PRACTICES UNIVERSITY OF CALIFORNIA RIVERSIDE CAMPUS HEALTH CENTER Effective Date: April 14, 2003 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationDISCLAIMER AMERICAN MEDICAL ASSOCIATION HOUSE OF DELEGATES (I-17) Report of Reference Committee B. Ralph J. Nobo, Jr., MD, Chair
DISCLAIMER The following is a preliminary report of actions taken by the House of Delegates at its 0 Interim Meeting and should not be considered final. Only the Official Proceedings of the House of Delegates
More informationNotice of Privacy Practices
River Valley Chiropractic LLC Notice of Privacy Practices Effective 9/2014; Revised 9/2014 If you have any questions about this notice, please contact the River Valley Chiropractic Privacy Officer at 308-534-5840.
More information79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled
79th OREGON LEGISLATIVE ASSEMBLY--2017 Regular Session Enrolled House Bill 2527 Sponsored by Representative BUEHLER, Senator STEINER HAYWARD; Representatives HACK, KENY-GUYER, SOLLMAN, Senator MONNES ANDERSON
More informationASHP Guidelines: Minimum Standard for Ambulatory Care Pharmacy Practice
Practice Settings Guidelines 535 ASHP Guidelines: Minimum Standard for Ambulatory Care Pharmacy Practice In recent years, there has been an increasing emphasis in health systems on the provision of ambulatory
More informationNotice of Privacy Practices
Notice of Privacy Practices This notice describes how medical information about you may be used and disclosed, and how you can get access to this information. Please review it carefully. Our commitment
More informationUniform Interstate Emergency Healthcare Services Act Drafting Committee Meeting April 28-29, 2006, Washington, D.C. Issues for Discussion
Uniform Interstate Emergency Healthcare Services Act Drafting Committee Meeting April 28-29, 2006, Washington, D.C. Issues for Discussion Section 2. Definitions Disaster Relief Organizations. Should the
More informationPatient Consent Form
Alexander Raskin, M.D., Q.M.E. Assistant Clinical Professor UCLA School of Medicine ORTHOPEDIC SURGERY SPORTS MEDICINE ARTHROSCOPY 16311 Ventura Blvd., Suite 1150, Encino, CA 91436 T (818) 788-ORTHO (6784)
More informationHoward University College of Pharmacy. Preceptor Orientation May 2012
Howard University College of Pharmacy Preceptor Orientation 2012 2013 May 2012 OBJECTIVES Overview of College of Pharmacy The Role of Experiential Program Educational Goals for IPPE and APPE Preceptor
More informationA Bill Regular Session, 2017 HOUSE BILL 1628
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas st General Assembly A Bill Regular Session, HOUSE BILL By: Representative B. Smith By:
More informationBlock Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)
Block Coordinator & Contact Information: Credit(s) & format: Section I. Block Description & Goals Jeremy Hughes, PharmD Director for Experiential Education & Assistant Professor Office: Creighton Hall
More informationBON SECOURS RICHMOND NOTICE OF PRIVACY PRACTICES
BON SECOURS RICHMOND NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFEULLY.
More informationPharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.
Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A. Objectives: Pharmacist and Pharmacy Technician Learning Objectives: At the end of this activity, participants
More informationREPORT 5 OF THE COUNCIL ON MEDICAL SERVICE (I-09) Radiology Benefits Managers (Reference Committee J) EXECUTIVE SUMMARY
REPORT OF THE COUNCIL ON MEDICAL SERVICE (I-0) Radiology Benefits Managers (Reference Committee J) EXECUTIVE SUMMARY At the 00 Annual Meeting, the House of Delegates adopted as amended Resolution, which
More informationA Review of Senate Bill 808 and the Revised Class B Hospital Pharmacy Permit
A Review of Senate Bill 808 and the Revised Class B Hospital Pharmacy Permit January 23, 2015 Missouri Board of Pharmacy Kimberly Grinston, J.D. Executive Director Tom Glenski, R.Ph. Chief Inspector Missouri
More informationPharmacy Leadership and Administration Learning Experience Rev 12/16/16
Pharmacy Leadership and Administration Learning Activities (Longitudinal): Preceptors: Jordan Dow, PharmD MS FACHE (Regional Pharmacy Director); Michele Richmond, RPh (Outpatient Pharmacy Director); Maggie
More informationOVERVIEW OF THE USES AND DISCLOSURES OF PHI
PRIVACY 24.0 OVERVIEW OF THE USES AND DISCLOSURES OF PHI Scope: Purpose: All workforce members (employees and non-employees), including employed medical staff, management, and others who have direct or
More informationPGY1 Medication Safety Core Rotation
PGY1 Medication Safety Core Rotation Preceptor: Mike Wyant, RPh Hours: 0800 to 1730 M-F Contact: (541)789-4657, michael.wyant@asante.org General Description This rotation is a four week rotation in duration.
More informationInternational Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services
International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part
More informationPhysician-Assisted Death: Balancing the Rights of Providers, Patients, and Other Stakeholders
Physician-Assisted Death: Balancing the Rights of Providers, Patients, and Other Stakeholders ABA Washington Health Law Summit December 13, 2016 Washington, DC Pamela S. Kaufmann, Partner Hanson Bridgett
More informationERIE COUNTY MEDICAL CENTER CORPORATION NOTICE OF PRIVACY PRACTICES. Effective Date : April 14, 2003 Revised: August 22, 2016
ERIE COUNTY MEDICAL CENTER CORPORATION NOTICE OF PRIVACY PRACTICES Effective Date : April 14, 2003 Revised: August 22, 2016 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationNotice of Health Information Privacy Practices Acknowledgement
I understand that as part of my healthcare, Sonoma Valley Hospital and its medical staff creates, receives and maintains health records describing my health history, symptoms, examination and test results,
More informationScotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists
Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince
More informationADVANCED PLASTIC SURGERY, PLLC. NOTICE OF PRIVACY PRACTICES
Effective Date: July 1 st 2013 ADVANCED PLASTIC SURGERY, PLLC. NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES 1 Effective Date: April 14, 2003 Revised: September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO
More informationScope of Regulation Excerpt from Business and Professions Code Division 2, Chapter 6, Article 2
BOARD OF REGISTERED NURSING P.O Box 944210, Sacramento, CA 94244-2100 P (916) 322-3350 www.rn.ca.gov Scope of Regulation Excerpt from Business and Professions Code Division 2, Chapter 6, Article 2 2725.
More informationH 5497 S T A T E O F R H O D E I S L A N D
LC000 01 -- H S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, and Fellela
More informationPharmacy Technicians Practice and Procedures
(Question): Which of the following best describes the practice of pharmacy? (A): Providing pharmaceutical information to the public. (B): Art and science of preparing and dispensing medications. (C): Art
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationDepartment of Pharmacy Services PGY1 Residency Program. Residency Manual
Department of Pharmacy Services PGY1 Residency Program Residency Manual 1 TABLE OF CONTENTS I. Introduction II. General Program Goals III. Residency Program Purpose Statement IV. Program s Goals V. Residency
More informationPrivacy Practices Home Visit Doctor, LLC July 2017
Privacy Practices Home Visit Doctor, LLC July 2017 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationThe California End of Life Option Act (Patient s Request for Medical Aid-in-Dying)
Office of Origin: I. PURPOSE II. III. A. The California authorizes medical aid in dying and allows an adult patient with capacity, who has been diagnosed with a terminal disease with a life expectancy
More informationContribute to society, and. Act as stewards of their professions. As a pharmacist or as a pharmacy technician, I must:
Code of Ethics Preamble Pharmacists and pharmacy technicians play pivotal roles in the continuum of health care provided to patients. The responsibility that comes with being an essential health resource
More informationDun & Bradstreet Partner Code of Conduct
Dun & Bradstreet Partner Code of Conduct Dun & Bradstreet Global Compliance Hotline (U.S. and Canada) 800.261.8552 (Outside U.S. and Canada) Country Access Number, then 800.261.8552 https://dnb.alertline.com
More informationOrthopedic Specialty Clinic, Ltd. Updated 05/2014
Orthopedic Specialty Clinic, Ltd. Updated 05/2014 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationRULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION CHAPTER 0800-02-25 WORKERS COMPENSATION MEDICAL TREATMENT TABLE OF CONTENTS 0800-02-25-.01 Purpose and Scope
More informationProposed amendments to the Marihuana for Medical Purposes Regulations
Proposed amendments to the Marihuana for Medical Purposes Regulations Submission in response to the Canada Gazette publication on the proposed amendments to the Marihuana for Medical Purposes Regulations
More informationPRIVACY POLICY USES AND DISCLOSURES FOR TREATMENT, PAYMENT, AND HEALTH CARE OPERATIONS
PRIVACY POLICY As of April 14, 2003, the Federal regulation on patient information privacy, known as the Health Insurance Portability and Accountability Act (HIPAA), requires that we provide (in writing)
More informationUSE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION WITHOUT AUTHORIZATION
USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION WITHOUT AUTHORIZATION Policy The Health Science Center may disclose protected health information without a patient authorization in the following circumstances:
More informationACPE Standards for Continuing Pharmacy Education. Standard 1: Mission and Goals of CPE. Standard 1: Goal and Mission of the.
ACPE Standards for Continuing Pharmacy Education Standards Road Map Section I: Content Standard 1: Mission and Goals of CPE Program Section II: Delivery Section III: Assessment Section IV: Evaluation 1
More informationSUMMARY OF NOTICE OF PRIVACY PRACTICES
LAKE REGIONAL MEDICAL GROUP 54 HOSPITAL DRIVE OSAGE BEACH, MO 65065 SUMMARY OF NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU
More informationDECEMBER 6, 2016 MEDICAL ASSISTANCE IN DYING GUIDANCE FOR PHARMACISTS AND PHARMACY TECHNICIANS
DECEMBER 6, 2016 MEDICAL ASSISTANCE IN DYING GUIDANCE FOR PHARMACISTS AND PHARMACY TECHNICIANS Acknowledgments The PEI College of Pharmacists would like to thank the following regulatory authorities sharing
More informationTHE CHILDREN S INSTITUTE OF PITTSBURGH NOTICE OF PRIVACY PRACTICES
THE CHILDREN S INSTITUTE OF PITTSBURGH NOTICE OF PRIVACY PRACTICES Effective Date: October 30, 2006 Revised: July 24, 2013 Revised: January 18, 2016 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT
More informationPATIENT BILL OF RIGHTS & NOTICE OF PRIVACY PRACTICES
Helping People Perform Their Best PRIVACY, RIGHTS AND RESPONSIBILITIES NOTICE PATIENT BILL OF RIGHTS & NOTICE OF PRIVACY PRACTICES Request Additional Information or to Report a Problem If you have questions
More informationMid-Atlantic Legislative/Regulatory June 2018 Update
Mid-Atlantic Legislative/Regulatory June 2018 Update Please Note: CCHP has a pending legislation/regulation webpage located at the following link: http://cchpca.org/state-laws-and-reimbursement-policies
More informationMarch 5, March 6, 2014
William Lamb, President Richard Gelula, Executive Director March 5, 2012 Ph: 202.332.2275 Fax: 866.230.9789 www.theconsumervoice.org March 6, 2014 Marilyn B. Tavenner Administrator Centers for Medicare
More informationGUIDELINES FOR INTERACTIONS OF CLINICIANS AND RESEARCHERS WITH INDUSTRY
GUIDELINES FOR INTERACTIONS OF CLINICIANS AND RESEARCHERS WITH INDUSTRY Overview The overriding goal of these guidelines is to ensure to the fullest extent possible that the integrity of clinical and research
More informationPharmacy Management. 450 Pharmacy Management Positions
450 Pharmacy Management Positions Pharmacy Management Disposition of Illicit Substances (1522) To advocate that healthcare organizations be required to develop procedures for the disposition of illicit
More informationJOINT NOTICE OF PRIVACY PRACTICES
JOINT NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. Who Will Follow This Notice PLEASE REVIEW
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationCONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities
CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities More information about this form may be found at http://cpe.pharmacy.ufl.edu. NOTE: Minimum time before activity
More informationAPP PRIVILEGES IN RADIATION ONCOLOGY
APP PRIVILEGES IN RADIATION ONCOLOGY Education/Training Licensure (Initial and Reappointment) Required Qualifications Successful completion of a PA or NP program Current Licensure as a PA or RN in the
More informationAs Introduced. 131st General Assembly Regular Session H. B. No
131st General Assembly Regular Session H. B. No. 548 2015-2016 Representative Schuring Cosponsor: Representative Sprague A B I L L To amend sections 4723.43, 4723.44, 4729.01, and 4761.17 of the Revised
More informationPurpose: To establish guidelines for the clinical practice of Non-Physician Medical Practitioners (NPMP).
Purpose: To establish guidelines for the clinical practice of Non-Physician Medical Practitioners (NPMP). Policy: The Central California Alliance for Health (the Alliance) requires all NPMPs to meet the
More informationSenior Care Pharmacy Wichita
Senior Care Pharmacy Wichita 1402 S.RIDGE ROAD WICHITA, KS, 67209 Phone: 316-945-7455 Fax: 316-945-7457 Contact:- Carol Parsons Dear patient/responsible party, Effective immediately, each patient/responsible
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More information